Structure of Telmisartan CAS 144701-48-4

Telmisartan CAS 144701-48-4

/in , , /by

Identification
Properties
Safety Data
Specifications & Other Information
Links

Identification

CAS Number

144701-48-4

Name

Telmisartan

Synonyms

[1,1′-Biphenyl]-2-carboxylic acid, 4′-[(1,4′-dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl]- [ACD/Index Name]
144701-48-4 [RN]
4′-[(1,7′-Dimethyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)methyl]-2-biphenylcarbonsäure [German] [ACD/IUPAC Name]
4′-[(1,7′-Dimethyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)methyl]-2-biphenylcarboxylic acid [ACD/IUPAC Name]
4′-[(1,7′-Dimethyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)methyl]biphenyl-2-carbonsäure [German]
4′-[(1,7′-dimethyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)methyl]biphenyl-2-carboxylic acid
7144
Acide 4′-[(1,7′-diméthyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)méthyl]-2-biphénylcarboxylique [French] [ACD/IUPAC Name]
acide 4′-[(1,7′-diméthyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)méthyl]biphényl-2-carboxylique [French]
Kinzalmono [Trade name]
Micardis [Trade name]
Pritor [Trade name]
telmisartan [French] [INN]
Telmisartan [INN] [JAN] [USAN] [Wiki]
telmisartán [Spanish] [INN]
telmisartanum [Latin] [INN]
U5SYW473RQ
телмисартан [Russian] [INN]
تيلميسارتان [Arabic] [INN]
替米沙坦 [Chinese] [INN]
(1,1′-Biphenyl)-2-carboxylic acid, 4′-((1,4′-dimethyl-2′-propyl(2,6′-bi-1H-benzimidazol)-1′-yl)methyl)-
[1,1′-biphenyl]-2-carboxylic acid, 4′[(1,4′-dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl]
[144701-48-4]
1189889-44-8 [RN]
2-(4-{[4-methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-benzodiazol-1-yl]methyl}phenyl)benzoic acid
2-[4-[[4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl]methyl]phenyl]benzoic acid
2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid
2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propyl-benzimidazol-1-yl]methyl]phenyl]benzoic acid
2-[4-[[4-methyl-6-(1-methylbenzoimidazol-2-yl)-2-propyl-benzoimidazol-1-yl]methyl]phenyl]benzoic acid
4′-((1,4′-dimethyl-2′-propyl(2,6′-bi-1H-benzimidazol)-1′-yl)methyl)-(1,1′-biphenyl)-2-carboxylic acid
4-((1,7-dimethyl-2-propyl-1h,3h-[2,5-bibenzo[d]imidazol]-3-yl)methyl)-[1,1-biphenyl]-2-carboxylic acid
4′-((1,7′-dimethyl-2′-propyl-1H,3’H-[2,5′-bibenzo[d]imidazol]-3′-yl)methyl)-[1,1′-biphenyl]-2-carboxylic acid
4′-((4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid
4-(1,4-Dimethyl-2-propyl-2,6-bi-1H-benzimidazol-1-yl)methyl-1,1-biphenyl-2-carboxylicacid
4′-(1,7′-Dimethyl-2′-propyl-1H-[2,5′]bibenzoimidazolyl-3′-ylmethyl)-biphenyl-2-carboxylic acid
4′-?[(1,?4′-?DIMETHYL-?2′-?PROPYL[2,?6′-?BI-?1H-?BENZIMIDAZOL]-?1′-?YL)METHYL]-?[1,?1′-?BIPHENYL]-?2-?CARBOXYLIC ACID
4′-[(1,4′-dimethyl-2’propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl]-[1,1′-biphenyl]-2-carboxylic acid
4′-[(1,4′-dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl]-[1,1′-biphenyl]-2-carboxylic acid
4′[(1,4′-Dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl][1,1′-biphenyl]-2-carboxylic acid
4′-[(1,4′-Dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl][1,1′-biphenyl]-2-carboxylic acid
4′-[(1,7′-dimethyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)methyl][1,1′-biphenyl]-2-carboxylic acid
4-[(1,7-dimethyl-2-propyl-1h,3h-2,5-bibenzimidazol-3-yl)methyl]biphenyl-2-carboxylic acid
4′[(1,7′-dimethyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)methyl]biphenyl-2-carboxylic acid
4′-[[1,4′-Dimethyl-2′-propyl(2,6′-bi-1H-benzimidazol)-1′-yl]-methyl]-1,1′-biphenyl-2-carboxylic acid 1,1-dimethylethyl ester
4′-[[4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl]methyl]-2-biphenylcarboxylic acid
4′[(1,4′-Dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl][1,1′-biphenyl]-2-carboxylic acid
6624054 [Beilstein]
BAY-68-9291
BIBR 277 SE
BIBR 277;Micardis;Pritor;Telday
BIBR 277SE
BIBR277
BIBR-277SE
BIBR-277-SE
BR-72892
BSPBio_002738
C33H30N4O2
Carbon monoxide releasing molecule 3 |
DV2037500
Kinzal
MFCD00918125 [MDL number]
Micardis (TN)
MICARDIS HCT
Micardis®
MLS000759432
NCGC00095150-01
NCGC00095150-02
Pharmakon1600-01505261
Pritor®
SMR000466326
SPECTRUM1505261
Spectrum5_001053
Targit
Targit;Temax;BIBR277;Micardis
Telday
Teleact D
Telma
Telmisartan (JAN/USAN/INN)
Telmisartan (Micardis)
TELMISARTAN-D3
Telmisattan
Temax
TL8000991
TLS
UNII:U5SYW473RQ
UNII-U5SYW473RQ

Molecular Structure

Structure of Telmisartan CAS 144701-48-4

Structure of Telmisartan CAS 144701-48-4

SMILES

CCCc1nc2c(cc(cc2n1Cc3ccc(cc3)c4ccccc4C(=O)O)c5nc6ccccc6n5C)C

StdInChI

InChI=1S/C33H30N4O2/c1-4-9-30-35-31-21(2)18-24(32-34-27-12-7-8-13-28(27)36(32)3)19-29(31)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5-8,10-19H,4,9,20H2,1-3H3,(H,38,39)

StdInChIKey

RMMXLENWKUUMAY-UHFFFAOYSA-N

Molecular Formula

C33H30N4O2

Molecular Weight

514.62

MDL Number

MFCD00918125

Safety Data

Personal Protective Equipment

Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter

RIDADR

NONH for all modes of transport

WGK Germany

2

Specifications and Other Information of Our Telmisartan CAS 144701-48-4

Standard

EP, USP

GMP

LCFDA

Basic Patent Situation

US expiry date20140107
EU expiry date20120131 (20170130)
JP expiry date20170125

Package

According to customer requirements to packaging

Storage

Under the room temperature and away from light

Application

Used as the Angiotensin II Receptor Antagonist.

Links

This product is sold exclusively through our sales company Watson International Ltd, and please click the link below for details.
http://www.watson-int.com/telmisartan-cas-144701-48-4/